ayurvedic management for extra fat or cholesterol

A prospective active controlled randomized comparative parallel two-arm clinical study to evaluate the efficacy and safety of oral Cholesterol Care Juice a polyherbal formulation in patients suffering from dyslipidemia - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112734

Enrollment

Registered

2026-06-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E782- Mixed hyperlipidemia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having abnormal lipid profile. patient having BMI between 18.5 to 40kg/m

Exclusion criteria

Exclusion criteria: 1.Dyslipidemia due to drugs, e.g., glucocorticoids. 2.Patients have a recent history of MI, heart failure, and stroke. 3.Pregnant and lactating women 4. H/O Alcoholism 5. Known allergy or hypersensitivity to any of the drug 6.Known case of Immunosuppressive patients HIV. 7.Patients with a known case of Active infectious diseases- tuberculosis, hepatitis B. 8. Patients who cannot give valid consent such as mentally retarded, unconscious patients and psychiatric illness. 9. Patient participating in another investigational drug trial in the previous 30 days.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of oral Cholesterol Care Juice, a polyherbal formulation, in improving lipid profile parameters (total cholesterol, LDL-C, HDL-C, and triglycerides) in patients suffering from dyslipidemia.Timepoint: at 90 days	—

Secondary

Measure	Time frame
To assess the effect of the intervention on cardiovascular risk markers such as atherogenic index and LDL/HDL ratio. To observe changes in body mass index (BMI) and waist circumference during the study period. To evaluate the safety and tolerability of Cholesterol Care Juice through clinical assessment and laboratory investigations.(LFT,RFT,ECG,HbA1C) To monitor and document any adverse events during the study period to establish the safety profile of Cholesterol Care Juice. Timepoint: 90 days	—

Measure

Time frame

To assess the effect of the intervention on cardiovascular risk markers such as atherogenic index and LDL/HDL ratio. To observe changes in body mass index (BMI) and waist circumference during the study period. To evaluate the safety and tolerability of Cholesterol Care Juice through clinical assessment and laboratory investigations.(LFT,RFT,ECG,HbA1C) To monitor and document any adverse events during the study period to establish the safety profile of Cholesterol Care Juice. Timepoint: 90 days

—

Countries

India

Contacts

Public ContactDrJaimini Mahendrasinh Rathod

Parul Institute of Ayurveda

jaiminiguddi@gmail.com8200984866

Outcome results